Volume 84, issue 1, Janvier 1997

Point de vue

Clinical research on breast cancer: can we still afford our ambitions? (p.7-9)
Henri Roché

Articles originaux

Neoadjuvant chemotherapy of locally advanced breast cancer: historical comparison of 4 sequential combinations (p.10-6)
Jean-Marc Ferrero, Moïse Namer, Jean-François Dufour, Rémy Largillier, Anne Creisson, Eric Teissier, Jean-Christophe Machiavello, Michel Lallement, Jean Monticelli, Michel Abbes

Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases (p.17-24)
Akeila Bellahcène, Vincent Castronovo

Late delayed adjuvant tamoxifen in early breast cancer. Results of a cooperative randomized trial (p.25-30)
Thierry Delozier, Odile Switsers, Jean-Yves Génot, Jean-Michel Ollivier, Michel Héry, Moïse Namer, Marc Frenay, Pierre Kerbrat, Jean-Pierre Julien, Adnan Naja, Maud Janvier, Josette Macé-Lesec’h

Results of 3 neoadjuvant chemotherapy regimen for operable breast cancer (p.31-4)
Hervé Cure, Sabine Charrier, Jean-Pierre Ferrière, Isabelle Van Praagh, Isabelle Assier, Viviane Feillel, Monique De Latour, Jacques-Olivier Bay, Jean-Louis Achard, Jacques Dauplat, Philippe Chollet

Glutathione S-transferase mu 1 (GSTM1): breast cancer susceptibility gene (p.35-40)
Xavier Fontana, Isabelle Peyrotte, Eliane Valente, Charlie Rossi, Francette Ettore, Moïse Namer, Françoise Bussière

Germline BRCA1 mutations in patients from 36 families with breast and/or ovarian cancers in Northern France (p.41-6)
Jean-Philippe Peyrat, Philippe Vennin, Louis Hornez, Jacques Bonneterre

Hepatic resection for breast cancer metastasis. The concept of adjuvant surgery (p.47-50)
Marc Pocard, Rémy-Jacques Salmon

Endometrial cancer and tamoxifen. Discussion based on a case series (p.51-60)
Annie J. Sasco, Roland Ah-Song, Isabelle Gendre, Patrick Zlatoff, Jean-Yves Bobin, Philippe Hallonet, Bernard Leduc

Synthèses

Vaccination against the polymorphic epithelial mucine MUC1 commonly overexpressed in breast cancer (p.61-4)
Susy Marie Scholl, Pierre Pouillart

Current trends in histopathological assessment of breast cancer (p.65-8)
Xavier Sastre

Molecular mechanisms of tamoxifen resistance (p.69-75)
Nathalie Bachmann-Moisson, Muriel Barberi-Heyob, Jean-Louis Merlin

Revues

Imaging of breast neoplasms (p.77-82)
René Gilles, Jean-Félix Calafat, Henri Tristant

Somatic genetic alterations in breast cancer (p.83-96)
Ivan Bièche, Rosette Lidereau

Dose intensification in high-risk non metastatic breast cancer: a critical review (p.97-105)
Gérard Ganem

Question d'internat

Breast cancer (p.107-16)
Stéphane Oudard